Phio Pharmaceuticals Corp (PHIO) concluded trading on Thursday at a closing price of $1.74, with 5.99 million shares of worth about $10.43 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -71.78% during that period and on December 19, 2024 the price saw a loss of about -30.68%. Currently the company’s common shares owned by public are about 1.06M shares, out of which, 1.02M shares are available for trading.
Stock saw a price change of -39.40% in past 5 days and over the past one month there was a price change of -31.82%. Year-to-date (YTD), PHIO shares are showing a performance of -74.56% which decreased to -74.56% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $2.17 but also hit the highest price of $10.35 during that period. The average intraday trading volume for Phio Pharmaceuticals Corp shares is 64.41K. The stock is currently trading -34.74% below its 20-day simple moving average (SMA20), while that difference is down -37.21% for SMA50 and it goes to -62.55% lower than SMA200.
Phio Pharmaceuticals Corp (NASDAQ: PHIO) currently have 1.06M outstanding shares and institutions hold larger chunk of about 2.70% of that.
The stock has a current market capitalization of $1.84M and its 3Y-monthly beta is at 1.45. It has posted earnings per share of -$13.94 in the same period. It has Quick Ratio of 6.38 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for PHIO, volatility over the week remained 26.84% while standing at 12.59% over the month.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by H.C. Wainwright on August 05, 2020 offering a Buy rating for the stock and assigned a target price of $4 to it.
